Kangana Ranaut Announces Tanu Weds Manu 3, Confirms Film With Vijay Sethupathi
Kangana Ranaut has confirmed that she will be returning for Tanu Weds Manu 3.

Kangana Ranaut Announces Tanu Weds Manu 3, Confirms Film With Vijay Sethupathi |
Kangana Ranaut's latest film, Tejas, was released in theaters today, October 27, 2023. Recently, in an interview, the actress talked about her upcoming projects and revealed that she will be returning for Tanu Weds Manu 3.
In an interview with IMDb India, the Queen actress said that she has a couple of films lined up. She also confirmed a new film with Vijay Sethupathi, which is touted to be a thriller.
Next, Kangana has a film called Noti Binodini, which is also going on the floor soon. "Another film called Tanu Weds Manu 3—that's also one we're starting. So there are a couple of things that are lined up," added the actress. She also expressed her desire to work with Aanand L. Rai again, who directed Tanu Weds Manu: Returns.
However, earlier in 2015, Aanand told Hindustan Times that there would not be Tanu Weds Manu 3. “I won’t make a third part just because it is a brand or because it will work. Let’s not treat it like a series. Right now, there is no part three. I think I am done with the characters, at least for now," he said.
While R. Madhavan, who played the role of Manoj Kumar Sharma, aka Manu, told YouTuber Jaby Koay that a sequel to Tanu Weds Manu is not possible, "I think I am done with it. I don’t want to go back to being Manu now,” Madhavan added. However, the cast of Tanu Weds Manu 3 has not been revealed yet.
ALSO READ
RECENT STORIES
-
Top 3 Skipped, 4-6 Recommended: Why Seniority Is Perhaps Not The Only Criterion In SC Collegium’s... -
PB Fintech Shares Plunge 43% In Four Sessions As IRDAI Insurance Reform Fears Hit Prospects -
'Yeh Ek Zimmedari Hai': Ranbir Kapoor Says His Job Wasn't To Be 'Worthy' Of Playing Ram In Ramayana... -
Mouni Roy Turns 41 In Style, Shares Breezy Bikini Look From Goa Birthday Getaway | Pics Inside -
India Secures Zero US Tariff On Select Speciality Drugs, What Does It Mean For Pharma Companies?
